IP Library Granted Patent US 8,093,397
Granted Patent B2
US 8,093,397 · App. 12/287,116 · Granted Jan 10, 2012

Activators for oligonucleotide synthesis

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,093,397
App. No.
12/287,116
Granted
Jan 10, 2012
Kind
B2
Abstract

A process for the synthesis of oligonucleotides using phosphoramidite chemistry is provided. The process employs as activator a 1,1-dioxo-1,2-dihydro-1λ 6 -benzo[d]isothiazol-3-one, preferably in the presence of an organic base. The 1,1-dioxo-1,2-dihydro-1λ 6 -benzo[d]isothiazol-3-one is represented by the following structural formula: wherein p is 0 or an integer from 1 to 4; X7 is O or S; R for each occurrence is a substituent, preferably each independently, a halo, a substituted or unsubstituted aliphatic group, —NR11R12, —OR13, —OC(O)R13, —C(O)OR13, or cyano; or two adjacent R groups taken together with the carbon atoms to which they are attached form a six membered saturated or unsaturated ring; R11 and R12 are each, independently, —H, a substituted or unsubstituted aliphatic group, a substituted or unsubstituted aryl group, or a substituted or unsubstituted aralkyl group; and R13 is a substituted or unsubstituted aliphatic group, a substituted or unsubstituted aryl group, or a substituted or unsubstituted aralkyl group. Preferred organic bases are pyridine, 3-methylpyridine, or N-methylimidazole.

Claims (9)

1. A composition of matter for use in condensation reactions in the preparation of oligonucleotides comprising acetonitrile and an activator comprising an N-alkylimidazole and a 1,1-dioxo-1,2-dihydro-1λ 6 -benzo[d]isothiazol-3-one represented by the following structural formula:

wherein:

p is 0 or an integer from 1 to 4;

X 7 is O or S; and

R for each occurrence is a substituent selected from the group consisting of halo groups, aliphatic groups, —NR 11 R 12 , —OR 13 , —OC(O)R 13 , —C(O)OR 13 , cyano, aryl groups, heterocyclyl groups, —CHO, —COR 13 , —NHCOR 13 , aralkyl groups, and —SR 13 ; or two adjacent R groups taken together with the carbon atoms to which they are attached form a six membered saturated or unsaturated ring; wherein:

R 11 and R 12 are each, independently, —H, an aliphatic group, an aryl group, an aralkyl group; or together with the nitrogen to which they are attached form a 5 or 6-membered heterocyclic ring ; and

R 13 is an aliphatic group, an aryl group, or an aralkyl group.

2. A composition of matter according to claim 1 , wherein p is 0,X 7 is 0 and the concentration of the N-alkylimidazole and 1,1-dioxo-1,2-dihydro-1λ 6 -benzo[d]isothiazol-3-one is from 0.1M to 0.25M.

3. A composition of matter for use in condensation reactions in the preparation of oligonucleotides comprising acetonitrile, N-methylimidazole and a compound of formula:

Assignments (2)
CHANGE OF NAME Recorded Jul 12, 2012
From: AVECIA BIOTECHNOLOGY INC
To: NITTO DENKO AVECIA, INC.
Reel/Frame 028549/0910 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2008
From: SINHA, NANDA; ZEDALIS, WILLIAM EDWARD; MIRANDA, GREGORY KEITH
To: AVECIA BIOTECHNOLOGY, INC.
Reel/Frame 021748/0430 →